BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 18782590)

  • 1. Reverse genetics approaches to combat pathogenic arenaviruses.
    de la Torre JC
    Antiviral Res; 2008 Dec; 80(3):239-50. PubMed ID: 18782590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel antiviral strategies to combat human Arenavirus infections.
    Kunz S; de la Torre JC
    Curr Mol Med; 2005 Dec; 5(8):735-51. PubMed ID: 16375709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses.
    de la Torre JC
    Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E57-64. PubMed ID: 19751403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse Genetics Approaches to Control Arenavirus.
    Martínez-Sobrido L; Cheng BY; de la Torre JC
    Methods Mol Biol; 2016; 1403():313-51. PubMed ID: 27076139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity.
    Miranda PO; Cubitt B; Jacob NT; Janda KD; de la Torre JC
    ACS Infect Dis; 2018 May; 4(5):815-824. PubMed ID: 29405696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of live-attenuated arenavirus vaccines based on codon deoptimization.
    Cheng BY; Ortiz-Riaño E; Nogales A; de la Torre JC; Martínez-Sobrido L
    J Virol; 2015 Apr; 89(7):3523-33. PubMed ID: 25589652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines.
    Martinez-Sobrido L; de la Torre JC
    Expert Rev Vaccines; 2016 Sep; 15(9):1113-21. PubMed ID: 27118328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.
    Cheng BY; Ortiz-Riaño E; de la Torre JC; Martínez-Sobrido L
    J Virol; 2015 Jul; 89(14):7373-84. PubMed ID: 25972555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein.
    Cheng BYH; Nogales A; de la Torre JC; Martínez-Sobrido L
    Virology; 2017 Jan; 501():35-46. PubMed ID: 27855284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arenavirus reverse genetics for vaccine development.
    Ortiz-Riaño E; Cheng BYH; Carlos de la Torre J; Martínez-Sobrido L
    J Gen Virol; 2013 Jun; 94(Pt 6):1175-1188. PubMed ID: 23364194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arenavirus Quasispecies and Their Biological Implications.
    Grande-Pérez A; Martin V; Moreno H; de la Torre JC
    Curr Top Microbiol Immunol; 2016; 392():231-76. PubMed ID: 26472215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporter-Expressing, Replicating-Competent Recombinant Arenaviruses.
    Martínez-Sobrido L; de la Torre JC
    Viruses; 2016 Jul; 8(7):. PubMed ID: 27447662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arenavirus research and antiviral candidate].
    Tani H; Shuzo U
    Uirusu; 2018; 68(1):51-62. PubMed ID: 31105135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The High Degree of Sequence Plasticity of the Arenavirus Noncoding Intergenic Region (IGR) Enables the Use of a Nonviral Universal Synthetic IGR To Attenuate Arenaviruses.
    Iwasaki M; Cubitt B; Sullivan BM; de la Torre JC
    J Virol; 2016 Jan; 90(6):3187-97. PubMed ID: 26739049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor.
    Ortiz-Riaño E; Ngo N; Devito S; Eggink D; Munger J; Shaw ML; de la Torre JC; Martínez-Sobrido L
    J Virol; 2014 Jan; 88(2):878-89. PubMed ID: 24198417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arenavirus extinction through lethal mutagenesis.
    de la Torre JC
    Virus Res; 2005 Feb; 107(2):207-14. PubMed ID: 15649566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
    Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.
    Ngo N; Henthorn KS; Cisneros MI; Cubitt B; Iwasaki M; de la Torre JC; Lama J
    J Virol; 2015 Nov; 89(21):10924-33. PubMed ID: 26292327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cell-based luciferase assay amenable to high-throughput screening of inhibitors of arenavirus budding.
    Capul AA; de la Torre JC
    Virology; 2008 Dec; 382(1):107-14. PubMed ID: 18929379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel drug discovery approaches for treating arenavirus infections.
    Pasquato A; Kunz S
    Expert Opin Drug Discov; 2016; 11(4):383-93. PubMed ID: 26882218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.